CRISPR Therapeutics and MaxCyte expand clinical and commercial license agreement into oncology Nov. 12, 2018
Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases Nov. 12, 2018
Small-molecule hepcidin production inhibitor developed for treatment of anemia of chronic disease Nov. 12, 2018
Small-molecule inhibitor of urokinase plasminogen activator ameliorates multiple sclerosis in mice Nov. 12, 2018
RSS